FDA Inspection 904822 — Anna Balcerska
The FDA completed an inspection of Anna Balcerska on November 7, 2014 in Gdansk. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 7, 2014
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gdansk (Poland)
Additional Details
Clinical Investigator (CI)